Role of FKS Mutations in Candida glabrata: MIC Values, Echinocandin Resistance, and Multidrug Resistance

Candida glabrata is the second leading cause of candidemia in U.S. hospitals. Current guidelines suggest that an echinocandin be used as the primary therapy for the treatment of C. glabrata disease due to the high rate of resistance to fluconazole. Recent case reports indicate that C. glabrata resis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Pham, Cau D., Iqbal, Naureen, Bolden, Carol B., Kuykendall, Randall J., Harrison, Lee H., Farley, Monica M., Schaffner, William, Beldavs, Zintars G., Chiller, Tom M., Park, Benjamin J., Cleveland, Angela A., Lockhart, Shawn R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2014
Schlagworte:
Epidemiology and Surveillance
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4136002/
https://ncbi.nlm.nih.gov/pubmed/24890592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03255-14
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge